Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.54 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
| ▸ | MMP3 | P08254 | 1/20 | 0.54 |
| ▸ | MMP8 | P22894 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.43 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.43 |
| ▸ | KDM5A | P29375 | 3/20 | 0.42 |
| ▸ | FDPS | P14324 | 5/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL5052603 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL310173 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL6233901 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL5052596 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL1334842 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL4713937 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL647323 | 1.00 | MMP1 (0.54) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL31442966 | 0.97 | MMP1 (0.52) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL28193980 | 0.97 | MMP1 (0.52) | MMP1MMP2MMP3MMP8CA12 | |
| Phosphoric Acid SCHEMBL17726983 | 0.93 | S1PR2 (0.53) | MMP1MMP2MMP3MMP8LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4222147-B1 | THIADIAZOLONE DERIVATIVES AND THEIR USE AS AMPK AGONISTS FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS | BETAGENON AB (SE) | 2025-03-19 | — | — | EP | disclosed |
| EP-4222147-A1 | THIADIAZOLONE DERIVATIVES AND THEIR USE AS AMPK AGONISTS FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS | Betagenon Bio AB (SE) | 2023-08-09 | — | — | EP | disclosed |
| WO-2022069894-A1 | THIADIAZOLONE DERIVATIVES AND THEIR USE AS AMPK AGONISTS FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS | BETAGENON BIO AB (SE) | 2022-04-07 | — | — | WO | disclosed |
| WO-2009021978-A2 | COMPOUNDS CONTAINING CARBABORANE RESIDUES AND THE USE THEREOF IN MEDICINE, ESPECIALLY FOR USE IN TUMOUR THERAPY | UNIVERSITÄT LEIPZIG (DE) | 2009-02-19 | — | — | WO | disclosed |